Zheng, J., Yu, J., Yang, M., & Tang, L. (2019). Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition. Exp Ther Med.
Citação norma ChicagoZheng, Jianyun, Jianxin Yu, Min Yang, and Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Citação norma MLAZheng, Jianyun, Jianxin Yu, Min Yang, and Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.